Treatment Patterns and Survival in Locally Advanced or Metastatic Biliary Tract Cancer Using SEER Medicare Data

Background and Aims: Biliary tract cancer (BTC) is a rare, lethal, heterogeneous group of cancers often diagnosed at an advanced stage. While gemcitabine plus cisplatin is the standard of care for first-line treatment of locally advanced or metastatic BTC, no globally accepted standard of care curre...

Full description

Bibliographic Details
Main Authors: Mark D. Danese, Kabir Mody, Ramya Thota, Stacie C. Lindsey, Melinda Bachini, Reham Abdel-Wahab, François Audhuy, Jennifer Duryea, Sarah Bobiak
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Gastro Hep Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772572323000092